Formula Growth’s Cinemark Holdings CNK Stock Holding History

Formula Growth’s Portfolio CNK Stock Details CNK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-221,530	Closed	-$2.21M	–	142
2020 Q3	$2.21M	Buy	+221,530	New	+$2.76M	0.41%	69

Other funds holding CNK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Formula Growth's CNK Position: Q4 2020 in Review

Formula Growth sold out of Cinemark Holdings (CNK) in Q4 2020, closing a stake of 221,530 shares — an estimated $2.21M sold.

Formula Growth first reported a position in CNK in Q3 2020 and held it in 1 quarter. The position peaked at $2.21M in Q3 2020. 240 funds tracked by Wall St. Rank hold CNK as of Q4 2020.

Formula Growth reported no remaining Cinemark Holdings position as of Q4 2020 after selling out during the quarter.
Formula Growth sold 221,530 Cinemark Holdings shares in Q4 2020, an estimated $2.21M.
Formula Growth first reported a position in Cinemark Holdings in Q3 2020 and held it in 1 quarter.
Formula Growth's Cinemark Holdings position peaked at $2.21M in Q3 2020.
240 funds tracked by Wall St. Rank held Cinemark Holdings as of Q4 2020.

Based on Formula Growth's 13F filing for Q4 2020, filed 12 Feb 2021.